These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11157034)

  • 1. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer.
    Sunwoo JB; Herscher LL; Kroog GS; Thomas GR; Ondrey FG; Duffey DC; Solomon BI; Boss C; Albert PS; McCullugh L; Rudy S; Muir C; Zhai S; Figg WD; Cook JA; Mitchell JB; Van Waes C
    J Clin Oncol; 2001 Feb; 19(3):800-11. PubMed ID: 11157034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.
    Bucci MK; Rosenthal DI; Hershock D; Metz J; Devine P; Kligerman MM; Machtay M
    Am J Clin Oncol; 2004 Dec; 27(6):595-602. PubMed ID: 15577438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
    Rosenthal DI; Lee JH; Sinard R; Yardley DA; Machtay M; Rosen DM; Egorin MJ; Weber RS; Weinstein GS; Chalian AA; Miller LK; Frenkel EP; Carbone DP
    J Clin Oncol; 2001 Mar; 19(5):1363-73. PubMed ID: 11230480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.
    Dowell JE; Sinard R; Yardley DA; Aviles V; Machtay M; Weber RS; Weinstein GS; Chalian AA; Carbone DP; Rosenthal DI
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):97-101. PubMed ID: 10210547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.
    Steinberg L; Hassan M; Olmsted L; Sharan V; Stepnick D; Hoppel C; Mugharbil A; Subramanyan S; McGloin B; Mackay W; Strauss M
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Haas ML; Conley BA; Egorin MJ; Levy S; Sivasailam S; Herman JM; Jacobs MC; Gray WC; Ord RA; Aisner JA; Van Echo DA
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):49-56. PubMed ID: 10758304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer.
    Machtay M; Aviles V; Kligerman MM; Treat J; Weinstein GS; Weber RS; Mirza N; Chalian AA; Rosenthal DI
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):311-5. PubMed ID: 10760424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.
    Grecula JC; Smith RE; Rhoades CA; Sharma P; Agrawal A; Zhang H; Allen J; Goldman FP; Young D; Schuller DE
    Cancer; 2000 Dec; 89(12):2587-96. PubMed ID: 11135220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
    Cmelak AJ; Murphy BA; Burkey B; Douglas S; Shyr Y; Netterville J
    Head Neck; 2007 Apr; 29(4):315-24. PubMed ID: 17252600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
    Kies MS; Haraf DJ; Rosen F; Stenson K; List M; Brockstein B; Chung T; Mittal BB; Pelzer H; Portugal L; Rademaker A; Weichselbaum R; Vokes EE
    J Clin Oncol; 2001 Apr; 19(7):1961-9. PubMed ID: 11283128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck.
    Feher O; Martins SJ; Lima CA; Salvajoli JV; Simpson AJ; Kowalski LP
    Head Neck; 2002 Mar; 24(3):228-35. PubMed ID: 11891954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
    Citrin D; Mansueti J; Likhacheva A; Sciuto L; Albert PS; Rudy SF; Cooley-Zgela T; Cotrim A; Solomon B; Colevas AD; Russo A; Morris JC; Herscher L; Smith S; Van Waes C
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1040-6. PubMed ID: 19117692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
    Fury MG; Sherman EJ; Rao SS; Wolden S; Smith-Marrone S; Mueller B; Ng KK; Dutta PR; Gelblum DY; Lee JL; Shen R; Kurz S; Katabi N; Haque S; Lee NY; Pfister DG
    Ann Oncol; 2014 Mar; 25(3):689-694. PubMed ID: 24496920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies.
    Rosenthal DI; Okani O; Truelson JM; Fathallah-Shaykh H; Vuitch FM; Gazdar AF; Griener J; Landay M; Mendelsohn D; Tourville J; Hamilton L; Orr KY; McWhorter J; Carbone DP
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-81-S2-84. PubMed ID: 9045344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
    Rosen FR; Haraf DJ; Kies MS; Stenson K; Portugal L; List MA; Brockstein BE; Mittal BB; Rademaker AW; Witt ME; Pelzer H; Weichselbaum RR; Vokes EE
    Clin Cancer Res; 2003 May; 9(5):1689-97. PubMed ID: 12738722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules.
    Moreno-Jiménez M; Valero J; López-Picazo JM; Arbea L; Aristu J; Cambeiro M; Alcalde J; Martínez-Monge R
    Am J Clin Oncol; 2010 Apr; 33(2):137-43. PubMed ID: 19786847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
    Choy H; Yee L; Cole BF
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
    Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.